Long-term treatment with a phosphodiesterase type 5 inhibitor improves pulmonary hypertension secondary to heart failure through enhancing the natriuretic peptides-cGMP pathway (Q45125056)
Jump to navigation
Jump to search
scientific article published in November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term treatment with a phosphodiesterase type 5 inhibitor improves pulmonary hypertension secondary to heart failure through enhancing the natriuretic peptides-cGMP pathway |
scientific article published in November 2004 |
Statements
1 reference
Long-term treatment with a phosphodiesterase type 5 inhibitor improves pulmonary hypertension secondary to heart failure through enhancing the natriuretic peptides-cGMP pathway (English)
1 reference
Takashi Yamamoto
1 reference
Atsuyuki Wada
1 reference
Takayoshi Tsutamoto
1 reference
Masato Ohnishi
1 reference
Minoru Horie
1 reference
1 November 2004
1 reference
1 reference
44
1 reference
5
1 reference
596-600
1 reference
Identifiers
1 reference
1 reference